Influence of Mucosal and Parenteral Immunization with a Replication-Defective Mutant of HSV-2 on Immune Responses and Protection from Genital Challenge
- 1 March 1998
- Vol. 243 (1) , 178-187
- https://doi.org/10.1006/viro.1998.9047
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The importance of MHC‐I and MHC‐II responses in vaccine efficacy against lethal herpes simplex virus type 1 challengeImmunology, 1997
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2Vaccine, 1996
- Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccineVaccine, 1996
- Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virusVaccine, 1995
- Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1The Journal of Infectious Diseases, 1994
- Protein-Specific Cervical Antibody Responses to Primary Genital Herpes Simplex Virus Type 2 InfectionsThe Journal of Infectious Diseases, 1994
- Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptideJournal of General Virology, 1992
- Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2Journal of General Virology, 1990
- Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected CellsJournal of General Virology, 1968